Rush University Medical Center
Playback speed
10 seconds
Hodgkin Lymphoma: Managing Brentuximab Vedotin/CPI Dual Refractory Patients
By
Rush University Medical Center
FEATURING
Vaishalee Kenkre
By
Rush University Medical Center
FEATURING
Vaishalee Kenkre
21 views
May 27, 2022
Comments 0
Login to view comments.
Click here to Login
2nd Midwest Cellular Conference: Treatment Options for Advanced Hematologic Malignancies